臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu c h"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 586-610 / 1656 (共67頁)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-01-28T02:03:18Z	MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma	Ho I.-L.;Kuo K.-L.;Liu S.-H.-.;Chang H.-C.;Hsieh J.-T.;Wu J.-T.;Chiang C.-K.;Lin W.-C.;Tsai Y.-C.;Chou C.-T.;Hsu C.-H.;Pu Y.-S.;Shi C.-S.;Kuo-How Huang; Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; Chang H.-C.; Hsieh J.-T.; Wu J.-T.; Chiang C.-K.; Lin W.-C.; Tsai Y.-C.; Chou C.-T.; Hsu C.-H.; Pu Y.-S.; Shi C.-S.; KUO-HOW HUANG
臺大學術典藏	2021-01-28T02:02:58Z	Epigallocatechin Gallate Attenuates Partial Bladder Outlet Obstruction-induced Bladder Injury via Suppression of Endoplasmic Reticulum Stress-related Apoptosis - In Vivo Study	Hsieh J.-T.; Kuo K.-L.; Liu S.-H.; Shi C.-S.; Chang H.-C.; Lin W.-C.; Chou C.-T.; Hsu C.-H.; Liao S.-M.; Wang Z.-H.; Li C.-C.; KUO-HOW HUANG
臺大學術典藏	2021-01-28T02:02:45Z	Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study	Kuo K.-L.;Liu S.-H.;Lin W.-C.;Hsu F.-S.;Chow P.-M.;Chang Y.-W.;Yang S.-P.;Shi C.-S.;Hsu C.-H.;Liao S.-M.;Chang H.-C.;Kuo-How Huang; Kuo K.-L.; Liu S.-H.; Lin W.-C.; Hsu F.-S.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; KUO-HOW HUANG
臺大學術典藏	2021-01-28T02:02:44Z	The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study	Kuo K.-L.;Liu S.-H.;Lin W.-C.;Chow P.-M.;Chang Y.-W.;Yang S.-P.;Shi C.-S.;Hsu C.-H.;Liao S.-M.;Chang H.-C.;Kuo-How Huang; Kuo K.-L.; Liu S.-H.; Lin W.-C.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; KUO-HOW HUANG
臺大學術典藏	2021-01-28T02:02:43Z	Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study	Shi C.-S.;Kuo K.-L.;Chen M.-S.;Chow P.-M.;Liu S.-H.;Chang Y.-W.;Lin W.-C.;Liao S.-M.;Hsu C.-H.;Hsu F.-S.;Chang H.-C.;Kuo-How Huang; Shi C.-S.; Kuo K.-L.; Chen M.-S.; Chow P.-M.; Liu S.-H.; Chang Y.-W.; Lin W.-C.; Liao S.-M.; Hsu C.-H.; Hsu F.-S.; Chang H.-C.; KUO-HOW HUANG
臺大學術典藏	2021-01-28T01:07:01Z	Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers	Hsu C.-H.;Kun-Huei Yeh;Chen L.-T.;Liu J.M.;Jan C.-M.;Lin J.-T.;Chen Y.-C.;Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Chen L.-T.; Liu J.M.; Jan C.-M.; Lin J.-T.; Chen Y.-C.; Cheng A.-L.
臺大學術典藏	2021-01-28T01:07:00Z	Thymic carcinoma with autoimmune syndrome: Successful treatment with weekly infusional high-dose 5-fluorouracil and leucovorin	Hsu C.-H.;Kun-Huei Yeh;Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Cheng A.-L.
臺大學術典藏	2021-01-28T01:07:00Z	A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers	Kun-Huei Yeh;Cheng A.-L.;Lin M.-T.;Hong R.-L.;Hsu C.-H.;Lin J.-F.;Chang K.-J.;Lee P.-H.;Chen Y.-C.; KUN-HUEI YEH; Cheng A.-L.; Lin M.-T.; Hong R.-L.; Hsu C.-H.; Lin J.-F.; Chang K.-J.; Lee P.-H.; Chen Y.-C.
臺大學術典藏	2021-01-28T01:06:55Z	Concurrent chemoradiotherapy for locally advanced esophageal cancer - A pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil	Hsu C.-H.;Kun-Huei Yeh;Lui L.T.;Lee Y.-C.;Bu C.-F.;Wang H.-P.;Lin J.-T.;Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Lui L.T.; Lee Y.-C.; Bu C.-F.; Wang H.-P.; Lin J.-T.; Cheng A.-L.
臺大學術典藏	2021-01-28T01:06:54Z	Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil	Kun-Huei Yeh;Yeh S.-H.;Hsu C.-H.;Wang T.-M.;Ma I.-F.;Cheng A.-L.; KUN-HUEI YEH; Yeh S.-H.; Hsu C.-H.; Wang T.-M.; Ma I.-F.; Cheng A.-L.
臺大學術典藏	2021-01-28T01:06:53Z	P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection	Liang J.-T.;Huang K.-C.;Cheng Y.-M.;Hsu H.-C.;Cheng A.-L.;Hsu C.-H.;Kun-Huei Yeh;Wang S.-M.;Chang K.-J.; Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Wang S.-M.; Chang K.-J.
臺大學術典藏	2021-01-28T01:06:53Z	Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma	Huang C.-L.;Lin Z.-Z.;Su I.-J.;Chao T.-Y.;Tien H.-F.;Chang M.-C.;Huang M.-C.;Kao W.-Y.;Tang J.-L.;Kun-Huei Yeh;Wang C.-H.;Hsu C.-H.;Liu M.-Y.;Cheng A.-L.; Huang C.-L.; Lin Z.-Z.; Su I.-J.; Chao T.-Y.; Tien H.-F.; Chang M.-C.; Huang M.-C.; Kao W.-Y.; Tang J.-L.; KUN-HUEI YEH; Wang C.-H.; Hsu C.-H.; Liu M.-Y.; Cheng A.-L.
臺大學術典藏	2021-01-28T01:06:52Z	A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil	Hsu C.-H.;Cheng A.-L.;Hsu C.;Yang C.-H.;Lu Y.-S.;Lin C.-C.;Bu C.-F.;Kun-Huei Yeh; Hsu C.-H.; Cheng A.-L.; Hsu C.; Yang C.-H.; Lu Y.-S.; Lin C.-C.; Bu C.-F.; KUN-HUEI YEH
臺大學術典藏	2021-01-28T01:06:52Z	High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection	Liang J.-T.;Huang K.-C.;Lai H.-S.;Lee P.-H.;Cheng Y.-M.;Hsu H.-C.;Cheng A.-L.;Hsu C.-H.;Kun-Huei Yeh;Wang S.-M.;Tang C.;Chang K.-J.; Liang J.-T.; Huang K.-C.; Lai H.-S.; Lee P.-H.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Wang S.-M.; Tang C.; Chang K.-J.
臺大學術典藏	2021-01-28T01:06:50Z	Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma	Lu Y.-S.;Hsu C.;Li C.-C.;Kuo S.-H.;Kun-Huei Yeh;Yang C.-H.;Hsu C.-H.;Wu C.-Y.;Cheng A.-L.; Lu Y.-S.; Hsu C.; Li C.-C.; Kuo S.-H.; KUN-HUEI YEH; Yang C.-H.; Hsu C.-H.; Wu C.-Y.; Cheng A.-L.
臺大學術典藏	2021-01-28T01:06:50Z	Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract	Hsu C.;Shen Y.-C.;Yang C.-H.;Kun-Huei Yeh;Lu Y.-S.;Hsu C.-H.;Liu H.-T.;Li C.-C.;Chen J.-S.;Wu C.-Y.;Cheng A.-L.; Hsu C.; Shen Y.-C.; Yang C.-H.; KUN-HUEI YEH; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; Cheng A.-L.
臺大學術典藏	2021-01-28T01:06:49Z	Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer	Kun-Huei Yeh;Lu Y.S.;Hsu C.H.;Lin J.F.;Chao H.J.;Huang T.C.;Chung C.Y.;Chang C.S.;Yang C.H.;Cheng A.L.; KUN-HUEI YEH; Lu Y.S.; Hsu C.H.; Lin J.F.; Chao H.J.; Huang T.C.; Chung C.Y.; Chang C.S.; Yang C.H.; Cheng A.L.
臺大學術典藏	2021-01-28T01:06:48Z	Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer	Kun-Huei Yeh;Lu Y.-S.;Hsu C.-H.;Lin J.-F.;Hsu C.;Kuo S.-H.;Li Jr. S.;Cheng A.-L.; KUN-HUEI YEH; Lu Y.-S.; Hsu C.-H.; Lin J.-F.; Hsu C.; Kuo S.-H.; Li Jr. S.; Cheng A.-L.
臺大學術典藏	2021-01-28T01:06:48Z	Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment	Yang C.-H.;Chen M.-C.;Cheng A.-L.;Hsu C.-H.;Kun-Huei Yeh;Yu Y.-C.;Whang-Peng J.;Yang P.-C.; Yang C.-H.; Chen M.-C.; Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Yu Y.-C.; Whang-Peng J.; Yang P.-C.
臺大學術典藏	2021-01-28T01:06:47Z	A pathway for tumor necrosis factor-α-induced Bcl10 nuclear translocation: Bcl10 is up-regulated by NF-κB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus	Pei Y.Y.;Kuo S.-H.;Kun-Huei Yeh;Chuang S.-E.;Hsu C.-H.;Wen C.C.;Lin H.-I.;Gao M.;Cheng A.-L.; Pei Y.Y.; Kuo S.-H.; KUN-HUEI YEH; Chuang S.-E.; Hsu C.-H.; Wen C.C.; Lin H.-I.; Gao M.; Cheng A.-L.
臺大學術典藏	2021-01-28T01:06:46Z	Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer	Lin C.-C.;Hsu C.-H.;Cheng J.C.;Wang H.-P.;Lee J.-M.;Kun-Huei Yeh;Yang C.-H.;Lin J.-T.;Cheng A.-L.;Lee Y.-C.; Lin C.-C.; Hsu C.-H.; Cheng J.C.; Wang H.-P.; Lee J.-M.; KUN-HUEI YEH; Yang C.-H.; Lin J.-T.; Cheng A.-L.; Lee Y.-C.
臺大學術典藏	2021-01-28T01:06:45Z	Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma	Lin C.-C.;Kun-Huei Yeh;Yang C.-H.;Hsu C.;Tsai Y.-C.;Hsu W.-L.;Cheng A.-L.;Hsu C.-H.; Lin C.-C.; KUN-HUEI YEH; Yang C.-H.; Hsu C.; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2021-01-28T01:06:45Z	A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer	Lin C.-C.;Cheng A.-L.;Hsu C.-H.;Lu Y.-S.;Hsu C.;Kun-Huei Yeh;Wu C.-Y.;Huang C.-S.;Yang C.-H.; Lin C.-C.; Cheng A.-L.; Hsu C.-H.; Lu Y.-S.; Hsu C.; KUN-HUEI YEH; Wu C.-Y.; Huang C.-S.; Yang C.-H.
臺大學術典藏	2021-01-28T01:06:44Z	Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulation	Huang T.-C.; KUN-HUEI YEH; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2021-01-28T01:06:42Z	Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001	Kuo S.-H.;Hsu C.-H.;Chen L.-T.;Lu Y.-S.;Lin C.-H.;Yeh P.-Y.;Jeng H.-J.;Gao M.;Kun-Huei Yeh;Cheng A.-L.; Kuo S.-H.; Hsu C.-H.; Chen L.-T.; Lu Y.-S.; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; KUN-HUEI YEH; Cheng A.-L.

顯示項目 586-610 / 1656 (共67頁)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52907523 線上人數 : 774 教育部委託研究計畫計畫執行:國立臺灣大學圖書館